Debt to EBITDA ratio Analysis of Pliant Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of PLRX
Dec-23-0.075Very Poor Debt to EBITDA | Dec-22-0.106Very Poor Debt to EBITDA | Growth29.52% |
Debt to EBITDA Analysis of Pliant Therapeutics Inc
| Debt to EBITDA Ratio of PLRX rose handsomely by 29.52 % this year. |
| Debt to EBITDA Ratio with value of 0 was highest in Year Dec-20 in last Five Years. |
| Debt to EBITDA Ratio with value of -0.106 was lowest in Year Dec-22 in last Five Years. |
| Latest Debt to EBITDA Ratio with value of -0.075 is lower than Average Debt to EBITDA of -0.0440 in last five years. |
Other Debt to EBITDA Related Info of PLRX that may interest you.
Pliant Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| PLRX | 12.13 | 12.17 | 0.329 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| Low Stability Stock | |
FY - Historical Debt to EBITDA of Pliant Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Debt to EBITDA | -0.075 | -0.106 | -0.0392 | 0 | 0 | 0 | 0 |
| Change | 29.52 % | -170.74 % |
FY Chart of Debt to EBITDA of Pliant Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)